Haffner, Steven M.

Performance Characteristics of the New Definition of Diabetes

Lorenzo, C., & Haffner, S. M. (2010) · Diabetes Care

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 53

Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: Results from NAVIGATOR

Huffman, K. M., Sun, J.-L., Thomas, L., Bales, C. W., Califf, R. M., Yates, T., Davies, M. J., Holman, R. R., McMurray, J. J. V., Bethel, M. A., et al. (2014) · Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsPhysical Activity and Health

Cited by 45

Metabolic and Antihypertensive Effects of Combined Angiotensin Receptor Blocker and Diuretic Therapy in Prediabetic Hypertensive Patients With the Cardiometabolic Syndrome

Zappe, D. H., Sowers, J. R., Hsueh, W. A., Haffner, S. M., Deedwania, P. C., Fonseca, V. A., Keeling, L., & Sica, D. A. (2008) · The Journal of Clinical Hypertension

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 42

Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study

Brancati, F. L., Evans, M., Furberg, C. D., Geller, N., Haffner, S., Kahn, S. E., Kaufmann, P. G., Lewis, C. E., Nathan, D. M., Pitt, B., et al. (2012) · Clinical Trials

Statistical Methods in Clinical TrialsStatistical Methods in Epidemiology

Cited by 34

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29

Nondiabetic Mexican-Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites.

Haffner, S. M., Miettinen, H., & Stern, M. P. (1996) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Cited by 18

Relationship of plasma insulin concentration and insulin sensitivity to blood pressure. Is it modified by obesity?

Mykkanen, L., Haffner, S. M., Ronnemaa, T., Watanabe, R. M., & Laakso, M. (1996) · Journal of Hypertension

Diabetes, Cardiovascular Risks, and LipoproteinsBlood Pressure and Hypertension Studies

Cited by 17

Updated risk factors should be used to predict development of diabetes

Bethel, M. A., Hyland, K. A., Chacra, A. R., Deedwania, P., Fulcher, G. R., Holman, R. R., Jenssen, T., Levitt, N. S., McMurray, J. J. V., Boutati, E., et al. (2017) · Journal of Diabetes and its Complications

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 12

Chronic obstructive pulmonary disease and cardiovascular risk: Insights from the NAVIGATOR trial

de Barros e Silva, P. G. M., Califf, R. M., Sun, J.-L., McMurray, J. J. V., Holman, R., Haffner, S., Thomas, L., & Lopes, R. D. (2014) · International Journal of Cardiology

Chronic Obstructive Pulmonary Disease (COPD) ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 11